Loading...
Loading...
Found 45 Skills
Evidence-based Drug-Drug Interaction (DDI) assessment skill modeled after the Micromedex Drug-Reax methodology. Trigger this skill whenever the user types /drug-drug, mentions "drug interaction", "DDI", "drug-drug", "can I take X with Y", "interaction between", "交互作用", "併用", or asks whether two medications can be used together. This skill performs systematic literature retrieval via PubMed, CrossRef, and WebSearch, then produces a structured assessment report with Severity, Documentation, Onset, Mechanism, Clinical Effects, and Management — mirroring the Micromedex Drug-Reax classification framework. Even casual questions like "is it safe to combine A and B" should trigger this skill.
You are **Executive Summary Generator**, a consultant-grade AI system trained to **think, structure, and communicate like a senior strategy consultant** with Fortune 500 experience. You specialize ...
Conduct comprehensive, multi-round research that produces rich visual reports. Use when asked for "deep research", "comprehensive analysis", "compare frameworks", "evaluate options", "research the state of X", or any task requiring investigation across 10+ sources. NOT for quick lookups — this is a 5-15 minute deep dive that produces a briefing-quality artifact with screenshots, diagrams, tables, and cited findings.
Comprehensive drug-drug interaction (DDI) prediction and risk assessment. Analyzes interaction mechanisms (CYP450, transporters, pharmacodynamic), severity classification, clinical evidence grading, and provides management strategies. Supports single drug pairs, polypharmacy analysis (3+ drugs), and alternative drug recommendations. Use when users ask about drug interactions, medication safety, polypharmacy risks, or need DDI assessment for clinical decision support.
Provide comprehensive clinical interpretation of somatic mutations in cancer. Given a gene symbol + variant (e.g., EGFR L858R, BRAF V600E) and optional cancer type, performs multi-database analysis covering clinical evidence (CIViC), mutation prevalence (cBioPortal), therapeutic associations (OpenTargets, ChEMBL, FDA), resistance mechanisms, clinical trials, prognostic impact, and pathway context. Generates an evidence-graded markdown report with actionable recommendations for precision oncology. Use when oncologists, molecular tumor boards, or researchers ask about treatment options for specific cancer mutations, resistance mechanisms, or clinical trial matching.
Predict patient response to immune checkpoint inhibitors (ICIs) using multi-biomarker integration. Given a cancer type, somatic mutations, and optional biomarkers (TMB, PD-L1, MSI status), performs systematic analysis across 11 phases covering TMB classification, neoantigen burden estimation, MSI/MMR assessment, PD-L1 evaluation, immune microenvironment profiling, mutation-based resistance/sensitivity prediction, clinical evidence retrieval, and multi-biomarker score integration. Generates a quantitative ICI Response Score (0-100), response likelihood tier, specific ICI drug recommendations with evidence, resistance risk factors, and a monitoring plan. Use when oncologists ask about immunotherapy eligibility, checkpoint inhibitor selection, or biomarker-guided ICI treatment decisions.
Use when you want to improve response quality through meta-cognitive reasoning. Applies 15+ reasoning methods to reconsider and refine initial outputs.
Litigation Analysis Tool - In-depth Judgment Analysis, Generating Appeal/Retrial Decision Support
Request judgment from random humans when uncertain about subjective decisions. Crowdsourced opinions on tone, style, ethics, and reality checks. CRITICAL - Responses take minutes to hours (or may never arrive).
Generate exactly 5 probability-weighted options for a specific decision point. Forces unconventional alternatives beyond safe defaults. For quick decision-point analysis, NOT full design exploration (use brainstorming for that). Triggers on "대안", "alternatives", "옵션 뽑아", "options", "어떤 방법이", "아이디어", "다른 방법", "선택지".
A comprehensive traditional Chinese metaphysics agent ("Yi Jing" expert) that combines Mei Hua Yi Shu (Timing) with Gemini AI for modern interpretation.
Use when analyzing patient records, clinical notes, medical PDFs, FHIR data, or advising on how to present medical data in health-tech products — OCR interpretation, clinical summarization, differential diagnosis support, drug interaction flags